No Picture
Business News

Huawei CFO Meng’s U.S. extradition case hinges on key ruling in Canada on Wednesday

A Canadian judge will rule Wednesday on a key aspect of Huawei Technologies Chief Financial Officer Meng Wanzhou’s extradition to the United States, with a favourable judgment seen as paving the way for the release of the Chinese executive after 18 months of house arrest.

…read more […]

No Picture
Trading Ideas

3 “Strong Buy” Biotech Stocks Under $5 With Explosive Upside Potential

Which stocks are leading the pack out on Wall Street? Biotechs. Understandably, investors have taken a more cautious approach when navigating the confused financial environment, but focus is locking in on the biotech sector as it has been able to withstand the COVID-19-induced pressure on the market. Proving to be relatively defensive, the biotech indexes, XBI and IBB, have outperformed the broader market year-to-date, with each gaining over 10% compared to the S&P 500’s 8% decline.The space’s resilience combined with a limited impact on Q1 fundamentals and the elimination of macro headwinds regarding drug legislation, has caused sentiment surrounding 2H20 …read more […]

No Picture
Trading Ideas

Ralph Lauren posts bigger-than-expected loss as lockdowns hammer sales

While nearly half of Ralph Lauren’s stores in North America are now open, demand for clothing from high-end fashion companies is not expected to rebound quickly as the global economy enters a deep recession. Ralph Lauren said it expects its fiscal 2021 results to also be significantly hit by the health crisis. …read more […]

No Picture
Trading Ideas

Gilead & Arcus Join Forces For 10-Year Cancer Deal, Arcus Down 15% In Pre-Market

Gilead Sciences (GILD) and Arcus Biosciences (RCUS), an oncology-focused biopharma, have announced a 10-year partnership to co-develop and co-commercialize current and future therapeutic product candidates in Arcus’s pipeline.The agreement will also provide ongoing funding to support Arcus’s research and development programs. On the news GILD shares stayed flat in Wednesday’s pre-market, while RCUS dropped 15%.“We are very pleased to build on Gilead’s growing presence in immuno-oncology,” said Daniel O’Day, CEO of Gilead. “By gaining access to its broad, diverse pipeline and Arcus’s clear strengths in discovery and development, we believe that our partnership with Arcus will significantly accelerate our progress …read more […]

No Picture
Trading Ideas

3 “Perfect 10” Dividend Stocks That Tick all the Boxes

The S&P 500 has spent the month of May bouncing in the range between 2,800 and 3,000. While the index remains 11% below its all-time high, there is a cautious sense of optimism, that the worst of the bear market is behind us.Investors may be feeling upbeat, and anticipating a recovery in 2H20, but times are still volatile. To make sense of them, TipRanks offers the Smart Score, a comprehensive tool which analyzes every stock in the TipRanks database according to 8 interrelated factors. The data is measured and collated by sophisticated AI algorithms, and used to generate a single …read more […]